| Zim Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 541400 |
NSE Symbol : ZIMLAB |
P/E(TTM) : 42.07 |
|
ISIN Demat : INE518E01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.68 |
|
Book Value(₹) : 49.93 |
Market Cap(₹Cr) : 344.46 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 88.39 | 71.43 | 108.52 | 95.40 | 89.72 | 82.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 88.39 | 71.43 | 108.52 | 95.40 | 89.72 | 82.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.04 | 1.48 | 1.55 | 1.76 | 1.32 | 0.98 |
| Total Income | 90.44 | 72.90 | 110.07 | 97.16 | 91.04 | 82.98 |
| Total Expenditure | 82.22 | 67.09 | 93.28 | 83.63 | 81.33 | 74.13 |
| PBIDT | 8.22 | 5.81 | 16.79 | 13.53 | 9.71 | 8.86 |
| Interest | 3.16 | 3.30 | 2.91 | 2.73 | 2.89 | 2.86 |
| PBDT | 5.06 | 2.51 | 13.88 | 10.80 | 6.83 | 6.00 |
| Depreciation | 4.83 | 4.79 | 5.23 | 4.77 | 4.97 | 4.92 |
| Tax | 0.00 | 0.00 | 3.34 | 0.66 | 0.24 | 0.21 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.11 | -0.59 | -0.11 | 1.02 | 0.40 | 0.12 |
| Reported Profit After Tax | 0.12 | -1.69 | 5.42 | 4.35 | 1.22 | 0.76 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.12 | -1.69 | 5.42 | 4.35 | 1.22 | 0.76 |
| EPS (Unit Curr.) | 0.03 | -0.35 | 1.11 | 0.89 | 0.25 | 0.16 |
| EPS (Adj) (Unit Curr.) | 0.03 | -0.35 | 1.11 | 0.89 | 0.25 | 0.16 |
| Calculated EPS (Unit Curr.) | 0.02 | -0.35 | 1.11 | 0.89 | 0.25 | 0.16 |
| Calculated EPS (Adj) (Unit Curr.) | 0.02 | -0.35 | 1.11 | 0.89 | 0.25 | 0.16 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.10 | -1.39 | 4.45 | 3.57 | 1.00 | 0.62 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.10 | -1.39 | 4.45 | 3.57 | 1.00 | 0.62 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 48.74 | 48.73 | 48.73 | 48.73 | 48.73 | 48.73 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.30 | 8.13 | 15.47 | 14.18 | 10.82 | 10.80 |
| PBDTM(%) | 5.72 | 3.51 | 12.79 | 11.32 | 7.61 | 7.32 |
| PATM(%) | 0.14 | -2.37 | 4.99 | 4.56 | 1.36 | 0.93 |